The arrival of GLP-1 receptor agonists has revolutionized treatment options for obesity. Medscape Medical News hosted a panel of experts to discuss these potentially life-changing medications and answer questions from the audience. GLP-1 RAs can be used as a primary drug for patients with type 2 diabetes and obesity. They do not need to be renally dosed, but patients should consult with their nephrologist. GLP-1 RAs should be held before surgery, may cause beneficial effects on sleep-disordered breathing, and can be used in patients with bariatric surgery. Liver functions should be monitored, and intermittent fasting may help patients maintain weight loss after discontinuing GLP-1 RAs.
Source link
GLP-1s for Obesity: Your Questions Answered
